Latest News

New research has identified that a layer of CD4+ T cells around the central nervous system acts as a reservoir for HIV during antiviral therapy, enabling a "rebound" of the virus when the treatment is stopped.

Editing healthy immune cells with CRISPR safely thwarts the brain's resistance to them, helping researchers to harness immune cell function to treat neurological conditions.

EPFL researchers have combined low-power chip design, machine learning algorithms, and soft implantable electrodes to produce a neural interface that can identify and suppress symptoms of various neurological disorders.

A protein transferred from male to female fruit flies during mating may cause changes to the female's circadian rhythm.

A nerve stimulation therapy for restoring function in the limbs of people with spinal cord injuries has shown promise in animal studies.

An ultrafast functional MRI technique with increased resolution has been used to capture the dynamics of brain activity, which could help to improve deep brain stimulation therapies.

Turning a decades-old dogma on its head, a new study shows that the receptor for oxytocin, a hormone considered essential to forming social bonds, may not play the critical role that scientists have assigned to it for the past 30 years.

New research from the Institute of Psychiatry, Psychology & Neuroscience at King’s College London has established a blood-based test that could be used to predict the risk of Alzheimer’s disease up to 3.5 years before clinical diagnosis.

A high-fat or high-calorie diet can interfere with the signaling pathway between the brain and the gut, altering the brain's ability to regulate food intake.

A study shows that levodopa has the potential to reverse the effects of inflammation on brain reward circuitry, ultimately improving symptoms of depression.